Description: Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Home Page: www.medpace.com
5375 Medpace Way
Cincinnati,
OH
45227
United States
Phone:
513 579 9911
Officers
| Name | Title |
|---|---|
| Dr. August James Troendle M.D. | Chairman & CEO |
| Mr. Jesse J. Geiger BBA, CPA | President |
| Mr. Kevin M. Brady | CFO & Treasurer |
| Ms. Susan E. Burwig BSN, MA | Executive Vice President of Operations |
| Mr. Stephen P. Ewald J.D. | Chief Compliance Officer, General Counsel & Corporate Secretary |
| Brandon Ebken | Chief Information Officer |
| Ms. Lauren Morris | Associate Director of Investors Relations |
| Mr. Todd Meyers | Vice President of Business Development & Marketing |
| John T. Wynne MBA | Senior Vice President of Commercial Operations & Clinical Pharmacology Unit |
| Mr. Reinilde Heyrman M.D. | Chief Medical Officer of Medical Department |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 26.9542 |
|---|---|
| Trailing PE: | 30.7792 |
| Price-to-Book MRQ: | 12.3849 |
| Price-to-Sales TTM: | 4.98 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 5900 |